Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

A serial entrepreneur and a promising drug emerge from failed companies to pursue subsets of obesity patients, with or ...

Managing weight loss with telotristat ethyl in patients with metastatic pancreatic ductal adenocarcinoma may improve survival, although further research is needed.

Salk Institute researchers have identified a key protein that may help users of GLP-1 drugs such as Ozempic and Wegovy ...

A new study uncovers a novel mechanism through which brown fat is transformed into heat, offering protection against obesity-related diseases. Obesity affects 650 million people worldwide and signific ...

Dr. Anna Arthur discusses how the NOURISH trial is addressing food insecurity and malnutrition in patients undergoing ...

Recent findings indicate that widely used weight-loss medications might lead to muscle loss, including vital heart muscle, ...

According to the report, the carbon dioxide in sparkling water may help to prevent this by stimulating glycolysis, a process ...

Weight loss treatments Mounjaro and Zepbound are the primary growth engines for Eli Lilly right now, but the company has another enormous opportunity that's getting very little attention.

A study shows that patients with obesity and fatty liver-related cirrhosis who had bariatric (weight-loss) surgery significantly lowered their future risk of developing serious liver complications ...

Tony Benna's Sundance-premiered 'André is an Idiot' irreverently chronicles the last years in the life of advertising ...